TY  - GEN
AU  - Cuker,Adam
AU  - Bass,Ann D
AU  - Nadj,Congor
AU  - Agius,Mark A
AU  - Steingo,Brian
AU  - Selmaj,Krzysztof W
AU  - Thoits,Timothy
AU  - Guerreiro,Alexandre
AU  - Van Wijmeersch,Bart
AU  - Ziemssen,Tjalf
AU  - Meuth,Sven G
AU  - LaGanke,Christopher C
AU  - Thangavelu,Karthinathan
AU  - Rodriguez,Claudio E
AU  - Baker,Darren P
AU  - Margolin,David H
AU  - Jannsens,Ann
TI  - Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management
SN  - 1477-0970
PY  - 2020///1116
KW  - Adult
KW  - Alemtuzumab
KW  - administration & dosage
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunologic Factors
KW  - Incidence
KW  - Interferon beta-1a
KW  - Male
KW  - Middle Aged
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - drug therapy
KW  - Purpura, Thrombocytopenic, Idiopathic
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1177/1352458518816612
ER  -